Latest York City has identified its first case of Mpox Clade I, a more severe strain of the virus. The individual who tested positive had recently traveled internationally.
A New Strain Emerges
This marks the first known case of Mpox Clade I within the five boroughs of New York City. Since November 2024, eleven cases of this strain have been detected across the United States, primarily in individuals with recent travel history to outbreak areas in Africa.
According to the New York City Health Department, the risk to the public remains low. Officials emphasize there is currently no known local transmission of Mpox Clade I.
Vaccination Remains Key
The Health Department recommends that New Yorkers at risk for mpox receive and complete the two-dose JYNNEOS vaccine series. The second dose should be administered at least 28 days after the first.
What Happens Next?
If more cases are identified, the Health Department may issue further guidance to healthcare providers and the public. Vaccination recommendations could be updated based on the evolving situation. Continued monitoring of international travel patterns and potential transmission routes will likely be a priority.
Frequently Asked Questions
What is Mpox Clade I?
Mpox Clade I is a more severe strain of the Mpox virus.
Is the Mpox vaccine effective against Clade I?
The NYC Health Department recommends completing the two-dose vaccine series to maximize protection against mpox.
Where has Mpox Clade I been detected in the US?
Since November 2024, there have been 11 cases of Mpox Clade I across the country, often linked to international travel to Africa.
How will public health officials respond to further cases of Mpox Clade I in New York City?
